Case number 2:23-cv-00299
Endo Ventures Unlimited et al v. Nexus Pharmaceuticals Inc > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 25, 2024 | 38 | JUDGMENT signed by Deputy Clerk on 3/25/24. (cc: all counsel)(jad) (1) |
| Mar 25, 2024 | 37 | ORDER signed by Judge Brett H Ludwig on 3/25/24 that Nexus's Motion to Dismiss the First Amended Complaint 32 is GRANTED. The complaint is dismissed for lack of personal jurisdiction. Nexus's Motion to Dismiss the complaint 18 is DENIED as moot. The Motion to Restrict Document 30 is GRANTED. (cc: all counsel)(jad) (11) |
| Sep 25, 2023 | 36 | NOTICE of Appearance by Julianne M Hartzell on behalf of Nexus Pharmaceuticals Inc. Attorney(s) appearing: Julianne M. Hartzell; Thomas R. Burns; Isha S. Shah (Hartzell, Julianne) (2) |
| Aug 4, 2023 | 35 | REPLY BRIEF in Support filed by Nexus Pharmaceuticals Inc re 32 MOTION to Dismiss First Amended Complaint . (Wilbert, Johanna) (12) |
| Jul 21, 2023 | 34 | BRIEF in Opposition filed by Endo Ventures Unlimited Company, Operand Pharmaceuticals III Limited, Par Sterile Products LLC re 32 MOTION to Dismiss First Amended Complaint . (Attachments: # 1 Ex. A - Nexus Pharmaceuticals Homepage, # 2 Ex. B - Nexus Pharmaceuticals Celebrates Grand Opening of New Facility _ Nexus Pharmaceuticals, # 3 Ex. C - Nexus Pharmaceuticals to Build Industry-Leading Sterile Injectable Manufacturing Facility in Pleasant, # 4 Ex. D - WIS. Business License -NEXUS PHARMACEUTICALS, INC. (N050651), # 5 Ex. E - Nexus Pharmaceuticals_ Overview _ LinkedIn, # 6 Ex. F - Kenosha Area Business Alliance - Nexus Success Stories, # 7 Ex. G - Emerphed IQVIA)(Liro, Christopher) (0) |
| Jun 30, 2023 | 33 | BRIEF in Support filed by Nexus Pharmaceuticals Inc re 32 MOTION to Dismiss First Amended Complaint REDACTED. (Attachments: # 1 Restricted Brief ISO Motion to Dismiss, # 2 Exhibit A to Brief ISO Motion to Dismiss, # 3 Exhibit B to Brief ISO Motion to Dismiss, # 4 Public Declaration of O. Ahmed, # 5 Restricted Declaration of O. Ahmed, # 6 Exhibit C to the Declaration of O. Ahmed)This document and/or certain attachments are restricted to case participants and attorneys of record should use their efiling login and password to view this document(Wilbert, Johanna) (0) |
| Jun 30, 2023 | 32 | MOTION to Dismiss First Amended Complaint by Nexus Pharmaceuticals Inc. (Attachments: # 1 Text of Proposed Order)(Wilbert, Johanna) (0) |
| Jun 30, 2023 | 31 | BRIEF in Support filed by Nexus Pharmaceuticals Inc re 30 MOTION to Restrict Document . (Wilbert, Johanna) (4) |
| Jun 30, 2023 | 30 | MOTION to Restrict Document by Nexus Pharmaceuticals Inc. (Attachments: # 1 Text of Proposed Order)(Wilbert, Johanna) (0) |
| Jun 23, 2023 | 29 | TEXT ONLY ORDER signed by Judge Brett H. Ludwig on 6/23/2023 re: 28 Stipulated Joint Motion to Extend. The Court GRANTS the motion and extends the time for Defendant to respond to Plaintiff's first amended complaint. The response is now due on or before June 30, 2023. (cc: all counsel)(jad) (0) |
| Jun 23, 2023 | 28 | Stipulated MOTION for Extension of Time to File Answer to First Amended Complaint by Nexus Pharmaceuticals Inc. (Attachments: # 1 Text of Proposed Order)(Wilbert, Johanna) (0) |
| Jun 9, 2023 | N/A | Party Endo Ventures Limited terminated (vkb) (Entered: 06/12/2023) (0) |
| Jun 9, 2023 | 27 | DISCLOSURE Statement filed by Operand Pharmaceuticals III Limited Endo Ventures Limited, Par Sterile Products LLC (Liro, Christopher) Modified on 6/12/2023 (vkb) (2) |
| Jun 9, 2023 | 26 | DISCLOSURE Statement filed by Endo Ventures Unlimited Par Sterile Products LLC (Liro, Christopher) Modified on 6/12/2023 (vkb) (2) |
| Jun 9, 2023 | 25 | AMENDED COMPLAINT against Nexus Pharmaceuticals Inc filed by Endo Ventures Limited, Par Sterile Products LLC. (Attachments: # 1 Ex. A US10869845, # 2 Ex. B US11491121, # 3 Ex. C 2023-03-01 Nexus Press Release, # 4 Ex. D 2020-04 FDA-approved labeling for Nexus Emerphed RTU Vials, # 5 Ex. E Labeling for Nexuss Emerphed RTU Syringes, # 6 Ex. F Letter from FDA to Nexus)(Liro, Christopher) (0) |
| Jun 8, 2023 | 24 | REDACTED CORRECTED BRIEF in Support filed by defendant Nexus Pharmaceuticals Inc re 18 MOTION to Dismiss (vkb) (Additional attachment(s) added on 6/9/2023: # 1 RESTRICTED Corrected Brief in Support of Motion to Dismiss) (vkb) (Entered: 06/09/2023) (0) |
| Jun 8, 2023 | 23 | REDACTED CORRECTED DECLARATION of Omair Ahmed (vkb) (Additional attachment(s) added on 6/9/2023: # 1 RESTRICTED Corrected Declaration of Omair Ahmed) (vkb). (Entered: 06/09/2023) (0) |
| Jun 8, 2023 | 22 | TEXT ONLY ORDER signed by Judge Brett H. Ludwig on 6/8/2023 re: 21 Joint Motion for Extension of Time. The Court GRANTS the motion and extends the time for Plaintiff to respond to Defendant's Motion to Dismiss. The response is now due on or before June 30, 2023. The Court also GRANTS the joint motion to file corrected documents. The Clerk is directed to file ECF No. 21-3 as the Declaration of Omair Ahmed and ECF No. 21-4 as Defendants' Brief in Support of Motion to Dismiss. Finally, finding good cause, the Court GRANTS the Motions to Restrict Documents, ECF Nos. 14, 20, and 21. (cc: all counsel)(jad) (0) |
| Jun 7, 2023 | 21 | Joint MOTION for Extension of Time and File Corrected Documents by Nexus Pharmaceuticals Inc. (Attachments: # 1 Text of Proposed Order, # 2 Public Corrected Declaration of O. Ahmed, # 3 Sealed Corrected Declaration of O. Ahmed, # 4 Public Corrected Brief ISO Motion to Dismiss, # 5 Sealed Corrected Brief ISO Motion to Dismiss)This document and/or certain attachments are restricted to case participants and attorneys of record should use their efiling login and password to view this document(Wilbert, Johanna) (0) |
| Jun 7, 2023 | 20 | Unopposed MOTION to Restrict Document by Nexus Pharmaceuticals Inc. (Attachments: # 1 Text of Proposed Order)(Wilbert, Johanna) (0) |
| May 19, 2023 | 19 | Redacted BRIEF in Support filed by Nexus Pharmaceuticals Inc re 18 MOTION to Dismiss (Attachments: # 1 Restricted Brief, # 2 Letter, # 3 Letter)This document and/or certain attachments are restricted to case participants and attorneys of record should use their efiling login and password to view this document(Wilbert, Johanna) (0) |
| May 19, 2023 | 18 | MOTION to Dismiss by Nexus Pharmaceuticals Inc. (Attachments: # 1 Text of Proposed Order)(Wilbert, Johanna) (0) |
| May 19, 2023 | 17 | DECLARATION of Omair Ahmed PUBLIC (Attachments: # 1 Certificate of Good Standing)(Wilbert, Johanna) (0) |
| May 19, 2023 | 16 | Restricted DECLARATION of Omair Ahmed (Attachments: # 1 Certificate of Good Standing)This document and/or certain attachments are restricted to case participants and attorneys of record should use their efiling login and password to view this document(Wilbert, Johanna) (0) |
| May 19, 2023 | 15 | BRIEF in Support filed by Nexus Pharmaceuticals Inc re 14 MOTION to Restrict Document . (Wilbert, Johanna) (4) |
| May 19, 2023 | 14 | MOTION to Restrict Document by Nexus Pharmaceuticals Inc. (Attachments: # 1 Text of Proposed Order)(Wilbert, Johanna) (0) |
| May 19, 2023 | 13 | DISCLOSURE Statement by Nexus Pharmaceuticals Inc. (Wilbert, Johanna) (2) |
| May 12, 2023 | 12 | TEXT ONLY ORDER signed by Judge Brett H. Ludwig on 5/12/2023 re: 11 Stipulated Motion for Extension of Time. The Court GRANTS the motion and extends the time to file an answer to the complaint. The defendant's answer is now due on or before May 19, 2023. (cc: all counsel)(jad) (0) |
| May 11, 2023 | 11 | Stipulated MOTION for Extension of Time to File Answer by Nexus Pharmaceuticals Inc. (Attachments: # 1 Text of Proposed Order)(Wilbert, Johanna) (0) |
| Apr 5, 2023 | 10 | TEXT ONLY ORDER signed by Judge Brett H. Ludwig on 4/5/2023 re: 9 Stipulated Motion for Extension of Time. The Court GRANTS the motion and extends the time to file an answer to the complaint. The defendant's answer is now due on or before May 12, 2023. (cc: all counsel)(jad) (0) |
| Apr 4, 2023 | 9 | Stipulated MOTION for Extension of Time to File Answer by All Plaintiffs. (Attachments: # 1 Text of Proposed Order)(Liro, Christopher) (0) |
| Mar 30, 2023 | 8 | SUMMONS Returned Executed by All Plaintiffs; defendant served on 3/17/2023 (Liro, Christopher) (2) |
| Mar 24, 2023 | 7 | Magistrate Judge Jurisdiction Form filed by All Plaintiffs. (NOTICE: Pursuant to Fed.R.Civ.P. 73 this document is not viewable by the judge.) (Liro, Christopher) (0) |
| Mar 16, 2023 | N/A | Summons Issued as to Nexus Pharmaceuticals Inc. (vkb) (0) |
| Mar 15, 2023 | 6 | REQUEST for Issuance of Summons by All Plaintiffs (Liro, Christopher) (2) |
| Mar 9, 2023 | 5 | Report to the Commissioner of Patents and Trademarks (vkb) (1) |
| Mar 8, 2023 | 4 | NOTICE of Appearance by Aaron T Olejniczak on behalf of All Plaintiffs. Attorney(s) appearing: Aaron T. Olejniczak (Olejniczak, Aaron) (1) |
| Mar 8, 2023 | N/A | NOTICE Regarding assignment of this matter to Judge Brett H Ludwig; Consent/refusal forms for Magistrate Judge Dries to be filed within 21 days; the consent/refusal form is available here. (jcl) (0) |
| Mar 5, 2023 | 3 | DISCLOSURE Statement by Par Sterile Products, LLC. (Liro, Christopher) (2) |
| Mar 5, 2023 | 2 | DISCLOSURE Statement by Endo Ventures Limited. (Liro, Christopher) (2) |
| Mar 5, 2023 | 1 | COMPLAINT against Nexus Pharmaceuticals, Inc. by Endo Ventures Limited, Par Sterile Products, LLC. ( Filing Fee PAID $402 receipt number AWIEDC-4341274) (Attachments: # 1 Civil Cover Sheet, # 2 AO 120 Form, # 3 Ex. A US10869845, # 4 Ex. B US11491121, # 5 Ex. C 2023-03-01 Nexus Press Release, # 6 Ex. D 2020-04 FDA-approved labeling for Nexus Emerphed RTU Vials, # 7 Ex. E Labeling for Nexuss Emerphed RTU Syringes, # 8 Ex. F Letter from FDA to Nexus)(Liro, Christopher) (0) |
